LIGELIZUMAB ACHIEVES FREEDOM FROM DISEASE ACTIVITY IN CHRONIC SPONTANEOUS URTICARIA REGARDLESS OF PREVIOUS H1-ANTIHISTAMINE DOSE

被引:0
|
作者
Soong, W.
Sitz, K.
Bernstein, J.
Maurer, M.
Gimenez-Arnau, A.
Hua, E.
Severin, T.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P049
引用
收藏
页码:S27 / S28
页数:2
相关论文
共 50 条
  • [21] Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine
    Li, Jie
    Guo, Aiyuan
    Chen, Wangqing
    Bin, Lianghua
    He, Yijing
    Zhu, Wu
    Peng, Cong
    Yan, Siyu
    Chen, Mingliang
    Zhang, Jianglin
    Su, Juan
    Yi, Mei
    Liu, Zhaoqian
    Zhang, Wei
    Zeng, Weiqi
    Leung, Donald Y. M.
    Chen, Xiang
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (04) : 1386 - 1388
  • [22] Patients with h1-antihistamine-resistant chronic spontaneous urticaria have long disease duration and show little improvement in disease characteristics and burden with time
    Maurer, M.
    Staubach, P.
    Raap, U.
    Richter-Huhn, G.
    Chapman-Rothe, N.
    Baeumer, D.
    ALLERGY, 2018, 73 : 227 - 228
  • [24] Serum MRGPRX2 and substance P levels are biomarkers of disease activity rather than an antihistamine response in chronic spontaneous urticaria
    Cuc, Nguyen Thi Kim
    Minh, Vu Nguyet
    Lan, Pham Thi
    My, Le Huyen
    Doanh, Le Huu
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [25] Effect of omalizumab on angioedema in H1-antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Braeutigam, M.
    Canvin, J.
    Maurer, M.
    ALLERGY, 2016, 71 (08) : 1135 - 1144
  • [26] Complete freedom from chronic spontaneous urticaria signs and symptoms is associated with sleep and dermatology quality-of-life improvements: Data from the phase 2b ligelizumab study
    Bernstein, Jonathan A.
    Gimenez-Arnau, Ana
    Hide, Michihiro
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB35 - AB35
  • [27] The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria
    Choi, Jeong-Hee
    Lee, Dong Hun
    Song, Woo-Jung
    Choi, Mira
    Kwon, Jae-Woo
    Kim, Gun-Woo
    Kim, Myung Hwa
    Kim, Mi-Ae
    Kim, Min-Hye
    Kim, Byung-Keun
    Kim, Sujeong
    Kim, Joung Soo
    Kim, Jung Eun
    Kim, Ju-Young
    Kim, Joo-Hee
    Kim, Hyun Jung
    Kim, Hye One
    Kim, Hyo-Bin
    Roh, Joo Young
    Park, Kyung Hee
    Park, Kui Young
    Park, Han-Ki
    Park, Hyunsun
    Bae, Jung Min
    Byun, Ji Yeon
    Song, Dae Jin
    Ahn, Young Min
    Lee, Seung Eun
    Lee, Young Bok
    Lee, Joong Sun
    Lee, Ji Hyun
    Lim, Kyung-Hwan
    Youn, Sang Woong
    Chang, Yoon-Seok
    Jeon, You Hoon
    Jeon, Jiehyun
    Jue, Mihn-Sook
    Choi, Sun Hee
    Hur, Gyu-Young
    Lim, Dae Hyun
    Ye, Young-Min
    Park, Young Min
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2020, 12 (05) : 750 - 770
  • [28] Evaluation of Pharmacologic Treatments for H1 Antihistamine-Refractory Chronic Spontaneous Urticaria A Systematic Review and Network Meta-analysis
    Nochaiwong, Surapon
    Chuamanochan, Mati
    Ruengorn, Chidchanok
    Awiphan, Ratanaporn
    Tovanabutra, Napatra
    Chiewchanvit, Siri
    JAMA DERMATOLOGY, 2021, 157 (11) : 1316 - 1327
  • [29] Evidence Gaps in Clinical Trials of Pharmacologic Treatment for H1-Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Future Perspectives
    Nochaiwong, Surapon
    Chuamanochan, Mati
    Ruengorn, Chidchanok
    Thavorn, Kednapa
    PHARMACEUTICALS, 2022, 15 (10)
  • [30] Combination of Quetiapine Immediate Release and XR for H1-Antihistamine-Refractory Chronic Spontaneous Urticaria Comorbid With Depressive Disorder: A Case Report
    Yang, Chuan-Chi
    Liang, Chih-Sung
    Chu, Ching-Wen
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (06) : E727 - E728